The Vesseltrack technology is developed by CEO and Founder Jakob Find Madsen.
In collaboration with Odense University Hospital, Denmark, the clinical research has successfully validated the technology.
Vesseltrack has one patent pending and a second patent will be submitted in Q2 2019.